Venture Capital

Avolta, the world's top travel retailer, partners with Topsort to bring data-driven ads to airports, signaling a new era for commerce media.

As Wall Street giants embrace prediction markets, a summit in NYC signals a new era of forecasting. But a fierce regulatory battle looms over their future.

Upwind's new AI Agentic Pack introduces autonomous agents to hunt threats, promising to reshape cloud security by focusing on real-time risks.

ICON plc opens a state-of-the-art San Antonio research unit, aiming to accelerate drug development and improve the patient trial experience.

As aerial threats to the energy grid grow, a new partnership aims to deploy advanced drone detection to protect vital assets from espionage and attack.

A new platform launches to connect accessible tech startups with users and investors, aiming to unify a fragmented but powerful innovation ecosystem.

A successful rocket launch and recovery proves space is the new frontier for delivering goods anywhere on Earth in minutes, shaking up global logistics and defense.

With enrollment tripling, Edconic's partnerships with Vogue and Sotheby's show students now prefer portfolio-building experiences over traditional internships.

A new alliance between XRDNA and the University of Utah is building 'executable systems' that go beyond communication to actively coordinate the physical world.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

With a new strategic investor and a star executive on its board, Apreo Health is poised to advance its breakthrough BREATHE Airway Scaffold for severe emphysema.

As Dye & Durham preps its Q3 earnings call, all eyes are on its transformation plan after a streak of declining revenue and significant net losses.

A new alliance aims to develop first-in-class drugs for Alzheimer's and Parkinson's by targeting chronic brain inflammation, a key driver of disease.

The medical device maker posts its 14th straight growth quarter, with soaring profits and a strategic focus on the underserved bronchiectasis market.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

The parent of Stop & Shop and Food Lion has hired a top data scientist. Here's how this move will reshape your shopping experience and the grocery industry.

Replit's new vibecon conference, featuring Spike Jonze and Refik Anadol, aims to merge code and culture. But is it a strategic pivot or a new creative renaissance?

A Boston-area biotech is tackling a key bottleneck in drug manufacturing, promising to unlock a new generation of RNA therapeutics with its novel platform.